Disease / condition

Nasopharyngeal Carcinoma clinical trials

Free access to 325 studies·10+ countries·Updated daily86 recruiting
325
Total trials
10+
Countries
10+
Sponsors
86
Recruiting
By phase
Phase 2130
N/A78
Phase 374
Phase 118
Early Phase 113
By status
Recruiting86
Not yet recruit...74
Unknown74
Completed67
Active, not rec...10
Top countries
China244
Taiwan11
Singapore9
United States of America5
Malaysia3
Top sponsors
Sun Yat-sen Univer...93
Zhejiang Cancer Ho...16
Fudan University15
Fujian Cancer Hosp...10
Wei Jiang7
Recent trials
Latest clinical trials for Nasopharyngeal Carcinoma
NCT06389201Not yet recr...
Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
Affiliated Hospital of Nantong...China
NCT06383780·Phase 3Recruiting
Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
XIANG YANQUNChina
NCT06370026·Phase 1Not yet recr...
KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial
Sun Yat-sen UniversityChina
NCT06364826·Phase 2Not yet recr...
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
NCT06323239·Phase 2Not yet recr...
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Sun Yat-sen UniversityChina
NCT06301165·Phase 2Recruiting
TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma
Sun Yat-sen UniversityChina
NCT06259721·Phase 2Recruiting
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hosp...China
NCT06248840Terminated
Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma
Zeng ChanghaoChina
NCT06241612·Phase 3Not yet recr...
Individualized Elective Neck Irradiation in NPC Patients
Sun Yat-sen University
NCT06239727·Phase 3Not yet recr...
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Sun Yat-sen UniversityChina
NCT06156878·Phase 2Recruiting
PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy
Fudan UniversityChina
NCT06136962Not yet recr...
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
Fujian Cancer HospitalChina
NCT06129201Not yet recr...
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
Fifth Affiliated Hospital, Sun...China
NCT06118333·Phase 3Not yet recr...
A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical C...China
NCT06095167·Phase 3Not yet recr...
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
Fujian Cancer HospitalChina
NCT06093061·Phase 2Not yet recr...
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
National Cancer Centre, Singap...Singapore
NCT06097793·Phase 1Not yet recr...
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
Kousai Bio Co., Ltd.China
NCT06059261·Phase 2Not yet recr...
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Chongqing University Cancer Ho...
NCT06029270·Phase 2Not yet recr...
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI...
NCT06026878·Phase 3Recruiting
GNT Induction Treatment in Locally Advanced NPC
Air Force Military Medical Uni...China
About this record

Access comprehensive clinical trial information for Nasopharyngeal Carcinoma through Pure Global AI's free database. This collection includes 325 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 86 trials are actively recruiting participants.

Research for Nasopharyngeal Carcinoma is being conducted in China, Taiwan, Singapore and 7+ other countries. Leading sponsors include Sun Yat-sen University and Zhejiang Cancer Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 325 clinical trials studying Nasopharyngeal Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Sun Yat-sen University, Zhejiang Cancer Hospital, Fudan University, among others.